Hepatitis C Virus Testing Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2030

Description

Persistence Market Research has recently published an in-depth analysis of the global hepatitis c virus testing market, offering a comprehensive overview of key market dynamics, growth drivers, challenges, and emerging trends. This report provides valuable insights into the hepatitis c virus testing market, presenting exclusive data and statistics that forecast the market's growth trajectory from 2023 to 2030.

The market for hepatitis C virus testing is projected to grow at a Compound Annual Growth Rate (CAGR) of 5.8%, reaching a value of US$1,185.2 million by the conclusion of 2030, up from US$798.7 million in 2023.

Key Insights:

Hepatitis C Virus Testing Market Size (2023E): US$798.7 Mn

Projected Market Value (2030F): US$1,185.2 Mn

Global Market Growth Rate (CAGR 2023 to 2030): 5.8%

Historical Market Growth Rate (CAGR 2018 to 2022): 5.2%

Hepatitis C Virus Testing Market- Report Scope:

Hepatitis C virus (HCV) testing is vital for diagnosing and treating HCV infections globally. The testing involves detecting viral RNA or antibodies to confirm the virus's presence, enabling early intervention and reducing the risk of chronic complications. The market is growing due to factors like the rising incidence of HCV infections, technological advancements in more precise testing methods, government initiatives, and increased public awareness. The adoption of point-of-care testing and molecular diagnostics further contributes to the expanding global HCV testing industry.

Market Growth Drivers:

The global demand for hepatitis C virus (HCV) testing is driven by the persistent rise in HCV infections worldwide. HCV, primarily transmitted through contaminated blood contact, is linked to unsafe medical procedures and intravenous drug use. The World Health Organization estimates approximately 58 million individuals globally are affected by HCV, significantly contributing to liver-related illnesses. The chronic nature of HCV infections, potential severe complications, and specific high-risk groups, such as those born to infected mothers and drug users, emphasize the crucial need for effective testing. Geographical and demographic disparities in infection rates highlight the urgency for reliable testing in certain areas. Limited healthcare infrastructure adds challenges to timely identification and intervention. Comprehensive testing is crucial due to the asymptomatic nature of HCV infections, preventing covert dissemination within communities.

Market Restraints:

The global HCV testing market faces significant obstacles due to economic difficulties in specific regions, limiting resources for comprehensive testing initiatives. Developing nations struggle with constrained healthcare budgets, hindering the adoption of advanced testing technologies. Another challenge is the presence of undetected and asymptomatic cases, delaying diagnosis and contributing to the continuous transmission of the virus within communities.

Market Opportunities:

The global HCV testing market benefits from the growing emphasis on proactive screening initiatives and preventive healthcare. Increased awareness of HCV as a public health concern has led to investments in public health campaigns, educating the public about the importance of early detection and effective treatments. This heightened awareness encourages voluntary testing, creating a favorable environment for market expansion. HCV testing is now integrated into routine health examinations and community health programs, with primary care providers increasingly incorporating screening into patient care. The prevalence of point-of-care testing technologies further facilitates HCV detection, contributing to broader accessibility in various healthcare settings. Overall, strategic inclusion of HCV testing in preventive healthcare programs helps reduce the global burden of HCV-associated liver diseases.

Key Questions Answered in the Report:

What are the key factors driving the growth of the hepatitis c virus testing market?
Which industry verticals are driving the demand for hepatitis c virus testing?
How are technological advancements reshaping the competitive landscape of the hepatitis c virus testing market?
Who are the leading players in the global hepatitis c virus testing market?
What are the emerging trends and future prospects in the global hepatitis c virus testing market?

Competitive Intelligence and Business Strategy:

Key players in the global HCV testing industry, such as Bio-Rad Laboratories, Abbott Laboratories, Roche Diagnostics, and Siemens Healthineers, maintain market leadership through continuous innovation. They invest heavily in research and development for advanced HCV testing solutions, forming strategic alliances with healthcare providers globally. Abbott Laboratories, for instance, partners with healthcare institutions to integrate testing solutions into standard procedures. These industry leaders also prioritize marketing and public awareness initiatives, actively participating in conferences to establish authority in the field and foster brand awareness.

Key Companies Profiled:
OraSure Technologies, Inc.
Abbott Laboratories Inc.
Siemens Healthcare GmbH
Bio Rad Laboratories Inc.

Ortho Clinical Diagnostic Inc. (Johnson & Johnson)

Bayer AG
QIAGEN N.V.

Thermo Fisher Scientific Inc.

BioGenex
AccuQuick,

Roche Diagnostics (F. Hoffman-La Roche Ltd.)

STD Rapid Test Kits

Hepatitis C Virus Testing Market Segmentation:

By Technique:

Immunoassays-based Hepatitis C Virus Testing

Polymerase Chain Reaction-based (PCR) Hepatitis C Virus Testing

Other Hepatitis C Virus Testing Techniques

By Test Type:
HCV Antibody Testing
HCV Viral Load Testing
HCV Genotyping Testing
By End User:
Hospitals
Diagnostic Centers
Blood Donation Centers
By Region:
North America
Europe
East Asia
South Asia & Oceania
Latin America
Middle East & Africa

Product Code: PMRREP33718

1. Executive Summary

1.1. Global Hepatitis C Virus (HCV) Testing Market Snapshot, 2023 and 2030
1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations

2. Market Overview

2.1. Market Scope and Definition
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Challenges
- 2.2.5. Key Trends
2.3. Technique Lifecycle Analysis
2.4. Hepatitis C Virus (HCV) Testing Market: Value Chain
- 2.4.1. List of Raw Material Supplier
- 2.4.2. List of Manufacturers
- 2.4.3. List of Distributors
- 2.4.4. List of Applications
- 2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
- 2.7.1. Global Sectorial Outlook
- 2.7.2. Global GDP Growth Outlook
- 2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape

3. Global Hepatitis C Virus (HCV) Testing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

3.1. Key Highlights
- 3.1.1. Market Volume (Units) Projections
- 3.1.2. Market Size and Y-o-Y Growth
- 3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
- 3.2.1. Historical Market Size Analysis, 2013-2016
- 3.2.2. Current Market Size Forecast, 2018-2026
3.3. Global Hepatitis C Virus (HCV) Testing Market Outlook: Technique
- 3.3.1. Introduction / Key Findings
- 3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Technique, 2018 - 2022
- 3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technique, 2023 - 2030
  - 3.3.3.1. Immunoassays-based Hepatitis C Virus Testing
  - 3.3.3.2. Polymerase Chain Reaction-based (PCR) Hepatitis C Virus Testing
  - 3.3.3.3. Other Hepatitis C Virus Testing Techniques
3.4. Market Attractiveness Analysis: Technique
3.5. Global Hepatitis C Virus (HCV) Testing Market Outlook: Test Type
- 3.5.1. Introduction / Key Findings
- 3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Test Type, 2018 - 2022
- 3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2023 - 2030
  - 3.5.3.1. HCV Antibody Testing
  - 3.5.3.2. HCV Viral Load Testing
  - 3.5.3.3. HCV Genotyping Testing
3.6. Market Attractiveness Analysis: Test Type
3.7. Global Hepatitis C Virus (HCV) Testing Market Outlook: End User
- 3.7.1. Introduction / Key Findings
- 3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2018 - 2022
- 3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
  - 3.7.3.1. Hospitals
  - 3.7.3.2. Diagnostic Centers
  - 3.7.3.3. Blood Donation Centers
3.8. Market Attractiveness Analysis: End User

4. Global Hepatitis C Virus (HCV) Testing Market Outlook: Region

4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
- 4.3.1. North America
- 4.3.2. Europe
- 4.3.3. East Asia
- 4.3.4. South Asia and Oceania
- 4.3.5. Latin America
- 4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region

5. North America Hepatitis C Virus (HCV) Testing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 5.3.1. By Country
- 5.3.2. By Technique
- 5.3.3. By Test Type
- 5.3.4. By End User
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 5.4.1. U.S.
- 5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technique, 2023 - 2030
- 5.5.1. Immunoassays-based Hepatitis C Virus Testing
- 5.5.2. Polymerase Chain Reaction-based (PCR) Hepatitis C Virus Testing
- 5.5.3. Other Hepatitis C Virus Testing Techniques
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2023 - 2030
- 5.6.1. HCV Antibody Testing
- 5.6.2. HCV Viral Load Testing
- 5.6.3. HCV Genotyping Testing
5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 5.7.1. Hospitals
- 5.7.2. Diagnostic Centers
- 5.7.3. Blood Donation Centers
5.8. Market Attractiveness Analysis

6. Europe Hepatitis C Virus (HCV) Testing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 6.3.1. By Country
- 6.3.2. By Technique
- 6.3.3. By Test Type
- 6.3.4. By End User
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 6.4.1. Germany
- 6.4.2. France
- 6.4.3. U.K.
- 6.4.4. Italy
- 6.4.5. Spain
- 6.4.6. Russia
- 6.4.7. Turkiye
- 6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technique, 2023 - 2030
- 6.5.1. Immunoassays-based Hepatitis C Virus Testing
- 6.5.2. Polymerase Chain Reaction-based (PCR) Hepatitis C Virus Testing
- 6.5.3. Other Hepatitis C Virus Testing Techniques
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2023 - 2030
- 6.6.1. HCV Antibody Testing
- 6.6.2. HCV Viral Load Testing
- 6.6.3. HCV Genotyping Testing
6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 6.7.1. Hospitals
- 6.7.2. Diagnostic Centers
- 6.7.3. Blood Donation Centers
6.8. Market Attractiveness Analysis

7. East Asia Hepatitis C Virus (HCV) Testing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 7.3.1. By Country
- 7.3.2. By Technique
- 7.3.3. By Test Type
- 7.3.4. By End User
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 7.4.1. China
- 7.4.2. Japan
- 7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technique, 2023 - 2030
- 7.5.1. Immunoassays-based Hepatitis C Virus Testing
- 7.5.2. Polymerase Chain Reaction-based (PCR) Hepatitis C Virus Testing
- 7.5.3. Other Hepatitis C Virus Testing Techniques
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2023 - 2030
- 7.6.1. HCV Antibody Testing
- 7.6.2. HCV Viral Load Testing
- 7.6.3. HCV Genotyping Testing
7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 7.7.1. Hospitals
- 7.7.2. Diagnostic Centers
- 7.7.3. Blood Donation Centers
7.8. Market Attractiveness Analysis

8. South Asia & Oceania Hepatitis C Virus (HCV) Testing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 8.3.1. By Country
- 8.3.2. By Technique
- 8.3.3. By Test Type
- 8.3.4. By End User
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 8.4.1. India
- 8.4.2. Southeast Asia
- 8.4.3. ANZ
- 8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technique, 2023 - 2030
- 8.5.1. Immunoassays-based Hepatitis C Virus Testing
- 8.5.2. Polymerase Chain Reaction-based (PCR) Hepatitis C Virus Testing
- 8.5.3. Other Hepatitis C Virus Testing Techniques
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2023 - 2030
- 8.6.1. HCV Antibody Testing
- 8.6.2. HCV Viral Load Testing
- 8.6.3. HCV Genotyping Testing
8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 8.7.1. Hospitals
- 8.7.2. Diagnostic Centers
- 8.7.3. Blood Donation Centers
8.8. Market Attractiveness Analysis

9. Latin America Hepatitis C Virus (HCV) Testing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 9.3.1. By Country
- 9.3.2. By Technique
- 9.3.3. By Test Type
- 9.3.4. By End User
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 9.4.1. Brazil
- 9.4.2. Mexico
- 9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technique, 2023 - 2030
- 9.5.1. Immunoassays-based Hepatitis C Virus Testing
- 9.5.2. Polymerase Chain Reaction-based (PCR) Hepatitis C Virus Testing
- 9.5.3. Other Hepatitis C Virus Testing Techniques
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2023 - 2030
- 9.6.1. HCV Antibody Testing
- 9.6.2. HCV Viral Load Testing
- 9.6.3. HCV Genotyping Testing
9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 9.7.1. Hospitals
- 9.7.2. Diagnostic Centers
- 9.7.3. Blood Donation Centers
9.8. Market Attractiveness Analysis

10. Middle East & Africa Hepatitis C Virus (HCV) Testing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 10.3.1. By Country
- 10.3.2. By Technique
- 10.3.3. By Test Type
- 10.3.4. By End User
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 10.4.1. GCC
- 10.4.2. Egypt
- 10.4.3. South Africa
- 10.4.4. Northern Africa
- 10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technique, 2023 - 2030
- 10.5.1. Immunoassays-based Hepatitis C Virus Testing
- 10.5.2. Polymerase Chain Reaction-based (PCR) Hepatitis C Virus Testing
- 10.5.3. Other Hepatitis C Virus Testing Techniques
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2023 - 2030
- 10.6.1. HCV Antibody Testing
- 10.6.2. HCV Viral Load Testing
- 10.6.3. HCV Genotyping Testing
10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 10.7.1. Hospitals
- 10.7.2. Diagnostic Centers
- 10.7.3. Blood Donation Centers
10.8. Market Attractiveness Analysis

11. Competition Landscape

11.1. Market Share Analysis, 2022
11.2. Market Structure
- 11.2.1. Competition Intensity Mapping By Market
- 11.2.2. Competition Analog IC
- 11.2.3. Apparent Technique Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 11.3.1. OraSure Technologies, Inc.
  - 11.3.1.1. Overview
  - 11.3.1.2. Segments and Technique
  - 11.3.1.3. Key Financials
  - 11.3.1.4. Market Developments
  - 11.3.1.5. Market Strategy
- 11.3.2. Abbott Laboratories Inc.
  - 11.3.2.1. Overview
  - 11.3.2.2. Segments and Technique
  - 11.3.2.3. Key Financials
  - 11.3.2.4. Market Developments
  - 11.3.2.5. Market Strategy
- 11.3.3. Siemens Healthcare GmbH
  - 11.3.3.1. Overview
  - 11.3.3.2. Segments and Technique
  - 11.3.3.3. Key Financials
  - 11.3.3.4. Market Developments
  - 11.3.3.5. Market Strategy
- 11.3.4. Bio Rad Laboratories Inc.
  - 11.3.4.1. Overview
  - 11.3.4.2. Segments and Technique
  - 11.3.4.3. Key Financials
  - 11.3.4.4. Market Developments
  - 11.3.4.5. Market Strategy
- 11.3.5. Ortho Clinical Diagnostic Inc. (Johnson & Johnson)
  - 11.3.5.1. Overview
  - 11.3.5.2. Segments and Technique
  - 11.3.5.3. Key Financials
  - 11.3.5.4. Market Developments
  - 11.3.5.5. Market Strategy
- 11.3.6. Bayer AG
  - 11.3.6.1. Overview
  - 11.3.6.2. Segments and Technique
  - 11.3.6.3. Key Financials
  - 11.3.6.4. Market Developments
  - 11.3.6.5. Market Strategy
- 11.3.7. QIAGEN N.V.
  - 11.3.7.1. Overview
  - 11.3.7.2. Segments and Technique
  - 11.3.7.3. Key Financials
  - 11.3.7.4. Market Developments
  - 11.3.7.5. Market Strategy
- 11.3.8. Thermo Fisher Scientific Inc.
  - 11.3.8.1. Overview
  - 11.3.8.2. Segments and Technique
  - 11.3.8.3. Key Financials
  - 11.3.8.4. Market Developments
  - 11.3.8.5. Market Strategy
- 11.3.9. BioGenex
  - 11.3.9.1. Overview
  - 11.3.9.2. Segments and Technique
  - 11.3.9.3. Key Financials
  - 11.3.9.4. Market Developments
  - 11.3.9.5. Market Strategy
- 11.3.10. AccuQuick,
  - 11.3.10.1. Overview
  - 11.3.10.2. Segments and Technique
  - 11.3.10.3. Key Financials
  - 11.3.10.4. Market Developments
  - 11.3.10.5. Market Strategy
- 11.3.11. Roche Diagnostics (F. Hoffman-La Roche Ltd.)
  - 11.3.11.1. Overview
  - 11.3.11.2. Segments and Technique
  - 11.3.11.3. Key Financials
  - 11.3.11.4. Market Developments
  - 11.3.11.5. Market Strategy
- 11.3.12. STD Rapid Test Kits
  - 11.3.12.1. Overview
  - 11.3.12.2. Segments and Technique
  - 11.3.12.3. Key Financials
  - 11.3.12.4. Market Developments
  - 11.3.12.5. Market Strategy

12. Appendix

12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations